Transcription factors in the control of dendritic cell life cycle

被引:12
作者
Bharadwaj, Arpita S.
Agrawal, Devendi K.
机构
[1] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA
[2] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA
[3] Creighton Univ, Sch Med, Dept Internal Med, Omaha, NE 68178 USA
关键词
antigen presentation; dendritic cells; ikaros; PU.1; signaling pathways; transcription factors;
D O I
10.1007/BF02686091
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Dendritic cells (DCs) are potent antigen-presenting cells that guard all parts of the body. They have the unique ability to prime T cells and generate primary immune responses. Their journey beginning with the development from precursor cells and ending with their death is controlled by a group of transcription factors. Some of the transcription factors like PU.1 are involved in more than one stage of DC life. Other transcription factors including Ikaros and JAK3 are involved in the development of more than one cell type. For a long time, the cellular and molecular mechanisms underlying the development, differentiation, maturation, and other stages of DC life were not well understood. However, in recent years novel information has been published by many researchers to better understand the molecular mechanisms of the development and function of DCs in immunological diseases such as asthma, cancer, autoimmunity, and transplantation. This review will discuss the various transcription factors and signaling pathways involved in each stage of the life cycle of DCs.
引用
收藏
页码:79 / 96
页数:18
相关论文
共 107 条
[1]
Essential role for ICSBP in the in vivo development of murine CD8α+ dendritic cells [J].
Aliberti, J ;
Schulz, O ;
Pennington, DJ ;
Tsujimura, H ;
Sousa, CRE ;
Ozato, K ;
Sher, A .
BLOOD, 2003, 101 (01) :305-310
[2]
Myeloid development is selectively disrupted in PU.1 null mice [J].
Anderson, KL ;
Smith, KA ;
Conners, K ;
McKercher, SR ;
Maki, RA ;
Torbett, BE .
BLOOD, 1998, 91 (10) :3702-3710
[3]
Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells [J].
Anderson, KL ;
Perkin, H ;
Surh, CD ;
Venturini, S ;
Maki, RA ;
Torbett, BE .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1855-1861
[4]
MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223) [J].
Andreae, S ;
Buisson, S ;
Triebel, F .
BLOOD, 2003, 102 (06) :2130-2137
[5]
Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223) [J].
Andreae, S ;
Piras, F ;
Burdin, N ;
Triebel, F .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :3874-3880
[6]
Ikaros SUMOylation: Switching out of repression [J].
Arco, PGD ;
Koipally, J ;
Georgopoulos, K .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (07) :2688-2697
[7]
A critical pole for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-α, and contact sensitizers [J].
Arrighi, JF ;
Rebsamen, M ;
Rousset, F ;
Kindler, V ;
Hauser, C .
JOURNAL OF IMMUNOLOGY, 2001, 166 (06) :3837-3845
[8]
Dendritic cell-intrinsic expression of NF-κB1 is required to promote optimal Th2 cell differentiation [J].
Artis, D ;
Kane, CM ;
Fiore, J ;
Zaph, C ;
Shapira, S ;
Joyce, K ;
MacDonald, A ;
Hunter, C ;
Scott, P ;
Pearce, EJ .
JOURNAL OF IMMUNOLOGY, 2005, 174 (11) :7154-7159
[9]
Ashany D, 1999, J IMMUNOL, V163, P5303
[10]
Visualizing PU.1 activity during hematopoiesis [J].
Back, J ;
Allman, D ;
Chan, S ;
Kastner, P .
EXPERIMENTAL HEMATOLOGY, 2005, 33 (04) :395-402